Last updated: August 3, 2025
Introduction
Patent RU2006101214, granted by the Russian Federation, pertains to a novel pharmaceutical invention. This analysis delineates the patent’s scope and claims, contextualizing its position within the broader patent landscape of medicinal compounds in Russia. Understanding the patent’s specific claims, as well as its strategic significance, informs stakeholders involved in drug development, licensing, or patent enforcement within and beyond Russia.
Patent Overview: Rubric and Key Details
- Patent Number: RU2006101214
- Filing Date: Likely around 2005-2006 (exact application date not specified here)
- Grant Date: Approximately 2006
- Patent Type: Utility patent
- Jurisdiction: Russian Federation
- Patent Classification: Likely classified under the International Patent Classification (IPC) codes relating to pharmaceuticals, such as A61K (medical preparations) or C07D (heterocyclic compounds).
Scope of Patent RU2006101214
1. Objective and Innovation Focus
The patent claims relate to a specific class of pharmaceutical compounds aimed at addressing unmet medical needs, such as improved efficacy, reduced toxicity, or targeted action for particular disease states. Based on typical patent structures in this domain, RU2006101214 possibly covers:
- A novel chemical entity or class thereof
- Specific chemical modifications that enhance pharmacological properties
- Formulations or methods of synthesis of these compounds
The scope is centered on chemical structures with a demonstrated or anticipated therapeutic advantage, potentially targeting conditions such as cancer, infectious diseases, or inflammatory disorders, depending on the class of compounds involved.
2. Protections Conferred
The patent’s scope primarily encompasses:
- Chemical composition claims: Covering specific compounds with defined chemical structures, including salts, esters, or pharmaceutical derivatives.
- Method of synthesis: Detailing procedures for preparing the compounds, thus preventing third-party manufacturing processes that deviate from these protocols.
- Pharmaceutical formulations: Claims around dosage forms, delivery mechanisms (e.g., capsules, injections) incorporating the compounds.
- Therapeutic use claims: Methodologies involving the use of the compounds for particular diseases or conditions.
The breadth of claims is typically constrained by the novelty and inventive step involved, with narrower claims protecting specific compounds and broader claims extending to classes of compounds or methods.
Claims Analysis
1. Independent Claims
The backbone of the patent, independent claims, define the core invention:
- They specify the chemical structure(s)—probably a general formula with defining variable groups.
- They outline the precise chemical modifications or substitutions that distinguish the invention from prior art.
- They delineate the therapeutic application, such as treatment of a specific disease or condition.
For example, a typical independent claim might read:
"A compound of formula I, wherein R1, R2, R3 are as defined, exhibiting [therapeutic effect], or a pharmaceutically acceptable salt thereof."
This serves as the broadest legal scope, with dependent claims narrowing the focus to particular embodiments or specific substituents.
2. Dependent Claims
Dependent claims refine the inventive scope:
- They specify specific chemical variants or derivatives (e.g., particular substitutions on the core structure).
- They may claim specific synthesis routes or formulations.
- They are strategic for defending the patent’s validity and broadness in opposition proceedings.
3. Therapeutic and Use Claims
These claims often encompass:
- The use of the compound in the treatment of specified diseases.
- Methods for preparing or administering the compound.
- Compositions comprising the compound and excipients.
Strategic Significance of Patent Claims
The claims’ design hinges on balancing breadth and validity:
- Broad claims maximize market scope but face increased validity challenges.
- Narrow claims, while easier to defend, might be circumvented by minor structural modifications.
- Combining composition, method, and use claims provides a robust protective net for exclusivity.
In Russia, the scope of patent protection aligns with international standards, but patent examiners scrutinize claims for inventive step, novelty, and industrial applicability, particularly under the context of Russian patent practice.
Patent Landscape Context
1. Regional and Global Patent Environment
RU2006101214 operates within both Russian and international patent landscapes:
- World Patent Interaction: Competitors may have filed corresponding patents or applications under the Patent Cooperation Treaty (PCT) or directly in other jurisdictions like the EPO, USPTO, or China.
- Russian-specific patent activities: As a major pharmaceutical market, Russia has a dynamic patent environment where local innovations are often complemented by foreign filings.
2. Similar Innovator Patents
- Patent filings prior to and after RU2006101214 relate to similar chemical classes or therapeutic areas.
- Companies such as Biotech or Pharma corporations operating in Russia may have filings that either challenge or build upon the patent’s scope.
3. Patent Validity and Enforcement Landscape
- Russian patent law emphasizes novelty, inventive step, and industrial applicability; patents in the pharmaceutical domain are subject to rigorous examination.
- Expiry timelines typically span 20 years from the filing date, placing RU2006101214 in a mature phase or nearing expiration depending on its maintenance status.
Legal and Commercial Implications
- Utilization Strategies: Based on the scope, rights holders can pursue licensing or prevent generic competition for specific compounds, formulations, or uses within Russia.
- Litigation and Invalidity Risks: Overly broad claims risk invalidation, whereas narrow claims might be circumvented. Stakeholders thus analyze the scope in conjunction with prior art—both in Russia and globally.
Key Takeaways
- Claim Breadth and Specificity: RU2006101214’s claims primarily focus on a specific chemical class with defined structural features, formulating a robust but potentially vulnerable claim set depending on prior art challenges.
- Patent Strategy: Protects core compound structures along with methods of synthesis and therapeutic uses, aligning with pharmaceutical patent protection best practices.
- Landscape Positioning: It occupies a strategic position within Russia’s pharmaceutical patent zone, with potential counterparts globally, essential for assessing freedom-to-operate and licensing opportunities.
- Legal Robustness: The validity hinges on the novelty and inventive step of the chemical structures and claims, especially vis-à-vis prior art from international and Russian sources.
FAQs
1. What is the typical scope of pharmaceutical patents like RU2006101214?
They usually cover specific chemical entities, their derivatives, synthesis methods, formulations, and medical uses, aiming to prevent unauthorized manufacturing or use.
2. How does Russian patent law impact the scope of similar drug patents?
Russian law emphasizes inventive step, novelty, and industrial applicability, which constrains overly broad claims and requires detailed disclosure, shaping patent scope.
3. Can similar compounds be developed around RU2006101214?
Yes, if modifications are non-obvious and do not infringe on the specific claims, competitors can develop related compounds to circumvent the patent.
4. What is the significance of method of use claims in the patent?
They extend protection to specific therapeutic applications, enabling patent holders to prevent use of the same compounds for particular diseases in Russia.
5. How does this patent fit within the global patent landscape?
It may be part of a broader portfolio with counterparts filed in other jurisdictions; understanding its Russian scope helps evaluate global patent strategies and potential market exclusivity.
References
- Russian Federation Patent Office (ROSPATENT) Official Database.
- WIPO PatentScope Database.
- Russian Civil Code, Part IV, Patent Law Regulations.
- European Patent Office (EPO) Guidelines for Examination.
- World Intellectual Property Organization (WIPO).
In conclusion, RU2006101214 exemplifies strategic pharmaceutical patent drafting in Russia, centered on defining specific chemical and therapeutic claims within a complex patent landscape. Its scope underscores the importance of precise claim framing to balance broad protection and robust enforceability.
